Post-ischemic shunt following hepatic ischemia/reperfusion does not affect tissue chemokine levels or tissue injury

Shock

Volumn 5, Issue 5, 1996, Pages 371-377

  Colletti, Lisa M ^a,b   Kunkel, Steven L ^a   Green, Maranne ^a   Burdick, Marie ^a   Strieter, Robert M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CXCL5 PROTEIN, HUMAN; DRUG DERIVATIVE; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; LIVER; MALE; METABOLISM; PATHOLOGY; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; CHEMOKINES, CXC; INTERLEUKIN-8; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030133349     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199605000-00010     Document Type: Article

References (26)

1. Keller GA, West ME, Cerra FB, Simmons RL: Macrophage-mediated modulation of hepatic function in multiple-system failure. J Surg Res 39:555-563, 1985.
2. Faist E, Baue AE, Dittmer H, Heberer A: Multiple organ failure in polytrauma patients. J Trauma 23:775-787, 1983.
3. Jaeschke H, Farhood A, Smith CW: Neutrophils contribute to ischemia/reperfusion injury in the rat liver in vivo. FASEB 4:3355-3359, 1990.
4. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr: Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion in the rat. J Clin Invest 85:1936-1943, 1990.
5. Colletti LM, Burtch GD, Remick DC, et al: The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 49:268-272, 1990.
6. Stricter RM, Lynch JP III, Basha MA, Standiford TJ, Kasahara K, Kunkel SL: Host responses in mediating sepsis and the adult respiratory distress syndrome. Semin Resp infect 5:233-247, 1990.
7. Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ: Neutrophil chemotactic factor produced by LPS-stimulated human blood mononuclear leukocytes: Partial characterization and separation from interleukin-1. J Immunol 139:788-793, 1987.
8. Colletti LM, Kunkel SL, Walz A, et al: Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat: The role of epithelial neutrophil-activating protein. J Clin Invest 95:134-141, 1995.
9. Colletti LM, Kunkel SL, Walz A, et al: The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 1995. In press.
10. 2 treatment. J Surg Res 40:167-175, 1986.
11. Strieter RM, Kunkel SL, Burdick MD, Lincoln PM, Walz A: The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. Immunol Invest 21:589-596, 1992.
12. Nguyen DT, Eskandari MK, DeForge LE, et al: Cylosporin A modulation of tumor necrosis alpha expression and effects in vitro and in vivo. J Immunol 144:3822-3828, 1990.
13. Goldblum SE, Wu KM, Jay M: Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol 59:1978-1985, 1985.
14. Duval DL, Howard D, McCalden TA, Billings RE: The determination of myeloperoxidase activity in liver. Life Sci 47:PL145-PL150, 1990.
15. Green TP, Johnson DE, Marchessault RP, Gatto CW: Transvascular flux and tissue accrual of Evans Blue: Effects of endotoxin and histamine. J Lab Clin Med 111:173-183, 1988.
16. Linderkamp O, Mader T, Butenandt O, Riegel KP: Plasma volume estimation in severely ill infants and children using a simplified Evans Blue method. Eur J Pediatr 125:135-141, 1977.
17. Saria A, Lundberg JM: Evans Blue fluorescence: Quantitative and morphological evaluation of vascular permeability in animal tissues. J Neurosci Methods 8:41-49, 1983.
18. Glantz SA: Alternatives to analysis of variance and the t test based on ranks. In Glantz SA (ed): Primer of Biostatistics. New York: McGraw-Hill Book Company, Inc., 1987, pp 287-331.
19. Jaeschke H, Farhood A, Smith CW: Neutrophils contribute to ischemia/reperfusion injury in the rat liver in vivo. FASEB 4:3355-3359, 1990.
20. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ, Smith CW: Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) mono-clonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology 17:915-923, 1993.
21. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D: Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Transplantation 55:1265-1272, 1993.
22. Langdale LA, Flaherty LC, Liggitt HD, Harlan JM, Rice CL, Winn RK: Neutrophils contribute to hepatic ischemia-reperfusion injury by a CD18-independent mechanism. J Leukocyte Biol 53:511-517, 1993.
23. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ: Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol 264:G801-G809, 1993.
24. Jaeschke H, Baustista AP, Spolarics Z, Spitzer JJ: Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J Leukocyte Biol 52:377-382, 1992.
25. Boermeester MA, Straatsburg IH, Houdijk APJ, et al: Endotoxin and interleukin-1-related hepatic inflammatory response promotes liver failure after partial hepatectomy. Hepatology 22:1499-1506, 1995.
26. Fausto N, Laird AD, Webber AM: Role of growth factors and cytokines in hepatic regeneration. FASEB J 9:1527-1536, 1995.